21771-89-1 Usage
Appearance
White to off-white crystalline powder A description of the physical form and color of the compound.
Solubility
Insoluble in water, soluble in organic solvents A property indicating the compound's ability to dissolve in different types of solvents.
Uses
Building block in the synthesis of pharmaceuticals and agrochemicals A specific application of the compound in the production of various drugs and chemicals used in agriculture.
Potential properties
Anti-inflammatory and analgesic Properties being studied for their possible effects in reducing inflammation and relieving pain.
Chemical structure
Phenylacetic acid core with a bromine atom and a phenyl group attached at different positions A description of the compound's molecular arrangement, which contributes to its versatility in the preparation of biologically active compounds.
Versatility
Intermediate for the preparation of various biologically active compounds A property indicating the compound's usefulness in creating other chemical compounds with potential biological activity.
Check Digit Verification of cas no
The CAS Registry Mumber 21771-89-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,7,7 and 1 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 21771-89:
(7*2)+(6*1)+(5*7)+(4*7)+(3*1)+(2*8)+(1*9)=111
111 % 10 = 1
So 21771-89-1 is a valid CAS Registry Number.
21771-89-1Relevant articles and documents
Efficient transformations of aldehydes and ketones into one-carbon homologated carboxylic acids
Katritzky, Alan R.,Toader, Dorin,Xie, Linghong
, p. 1425 - 1427 (1996)
Peterson olefination of aldehydes and ketones with trimethylsilyl(methoxy)(benzotriazol-1-yl)methyl anion 6 afforded 1-(benzotriazol-1-yl)-1-methoxyalk-1-enes 7 which were treated without isolation with zinc bromide and hydrochloric acid, to yield the corresponding one-carbon homologated carboxylic acids 4 in good overall yields.
LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS
-
Paragraph 0428, (2013/03/26)
Compounds, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds to treat, prevent or diagnose diseases, disorders, or conditions associated with one or more of the lysophosphatidic acid receptors are provided.
INHIBITORS OF HISTONE DEACETYLASE
-
Page/Page column 65, (2008/12/04)
This invention relates to compounds for the inhibition of histone deacetylase. More particularly, the invention provides for compounds of formula compounds of the Formula (I) and N-oxides, hydrates, solvates, pharmaceutically acceptable salts, prodrugs and complexes thereof, and racemic and scalemic mixtures, diastereomers and enantiomers thereof, wherein groups L, M, X and Y are as defined herein.
